Measurement of tafenoquine (WR 238605) in human plasma and venous and capillary blood by high-pressure liquid chromatography

Therapeutic Drug Monitoring

Volumn 22, Issue 2, 2000, Pages 184-189

  Kocisko, David A ^a   Walsh, Douglas S ^b   Eamsila, Chirapa ^b   Edstein, Michael D ^a  

^a AUSTRALIAN ARMY MALARIA INSTITUTE   (Australia)

^b ARMED FORCES RESEARCH INSTITUTE OF MEDICAL SCIENCES   (Thailand)

Author keywords

High pressure liquid chromatography; Malaria; Tafenoquine; WR 238605

Indexed keywords

TAFENOQUINE;

ARTICLE; CAPILLARY FLOW; DIAGNOSTIC ACCURACY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG MONITORING; FLOW KINETICS; FLUORESCENCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

AMINOQUINOLINES; ANTIMALARIALS; CALIBRATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS;

EID: 0034031718     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007691-200004000-00008     Document Type: Article

References (9)

1. Milhous WK, Brueckner RP, Theorides AD, Schuster BG. Preclinical efficacy of WR 238605. In: Programs and Abstracts of the 31st Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC: American Society for Microbiology; 1991:161.
2. Milhous WK, Robinson BL, Brueckner RP, Schuster BG, Peters W. Evaluation of WR 238605 in rodent malaria models. In: Program and abstracts of the 41st Annual Meeting of the American Society of Tropical Medicine and Hygiene. Northbrook, IL: American Society of Tropical Medicine and Hygiene; 1992:89.
3. Brueckner RP, Coster T, Wesche DL, Shmuklarsky M, Schuster BG. Prophylaxis of plasmodium falciparum infection in a human challenge model with WR 238605. a new 8-aminoquinoline antimalarial. Antimicrob Agents Chemother 1998;42:1293-1294.
4. Brueckner RP, Lasseter KC, Lin ET, Schuster BG. First-time-in-humans safety and pharmacokinetics of WR 238605, a new antimalarial. Am J Trop Med Hyg 1998;58:645-649.
5. Shanks GD, US Army Medical Research Unit-Kenya, Nairobi, Kenya, manuscript in preparation.
6. Karle JM, Olmeda R. Rapid and sensitive quantitative analysis of the new antimalarial N4-[2,6-dimethoxy-4-methyl-5-[(3-trifluoromethyl)phenoxy]-8-quinolinyl] -1,4-pentanediamine in plasma by liquid chromatography and electrochemical detection. J Chromatogr 1988;424:347-356.
7. Karle JM, Olmeda R, Freeman SG, Schroeder AC. Quantification of the individual enantiomer plasma concentrations of the candidate antimalarial agent N4-[2,6-dimethoxy-4-methyl-5-[(3-trifluoromethyl)phenoxy]-8-quinolinyl]-1,4- pentanediamine (WR 238605). J Chromatogr B 1995;670:251-257.
8. Bergqvist Y, Hellgren U, Churchill FC. High-pressure liquid chromatographic assay for the simultaneous monitoring of mefloquine and its acid metabolite in biological samples using protein precipitation and ion-pair extraction. J Chromatogr 1988;432:253-263.
9. Sheiner LB, Beal SL. Some suggestions for measuring predictive performance. J Pharmacokinet Biopharm 1981;9:503-512.